Cover - USD ($) | 12 Months Ended | | |
Dec. 31, 2022 | Mar. 21, 2023 | Jun. 30, 2022 |
Cover [Abstract] | | | |
Document Type | 10-K/A | | |
Amendment Flag | true | | |
Amendment Description | This Amendment No. 1 to the Annual Report on Form 10-K/A (this “Amendment”) amends the Annual Report on Form 10-K for the year ended December 31, 2022 (the “Original Report”) of Abeona Therapeutics Inc. (the “Company”), which was filed with the Securities and Exchange Commission (“SEC”) on March 29, 2023. This Amendment is being filed solely to amend the signature page to remove the conformed signature of one of the Company’s directors, which was inadvertently included in the Original Report. In addition, the Company has updated the address | | |
Document Annual Report | true | | |
Document Transition Report | false | | |
Document Period End Date | Dec. 31, 2022 | | |
Document Fiscal Period Focus | FY | | |
Document Fiscal Year Focus | 2022 | | |
Current Fiscal Year End Date | --12-31 | | |
Entity File Number | 001-15771 | | |
Entity Registrant Name | ABEONA THERAPEUTICS INC. | | |
Entity Central Index Key | 0000318306 | | |
Entity Tax Identification Number | 83-0221517 | | |
Entity Incorporation, State or Country Code | DE | | |
Entity Address, Address Line One | 6555 Carnegie Ave | | |
Entity Address, Address Line Two | 4th Floor | | |
Entity Address, City or Town | Cleveland | | |
Entity Address, State or Province | OH | | |
Entity Address, Postal Zip Code | 44103 | | |
City Area Code | (646) | | |
Local Phone Number | 813-4701 | | |
Title of 12(b) Security | Common Stock, $0.01 par value | | |
Trading Symbol | ABEO | | |
Security Exchange Name | NASDAQ | | |
Entity Well-known Seasoned Issuer | No | | |
Entity Voluntary Filers | No | | |
Entity Current Reporting Status | Yes | | |
Entity Interactive Data Current | Yes | | |
Entity Filer Category | Non-accelerated Filer | | |
Entity Small Business | true | | |
Entity Emerging Growth Company | false | | |
Entity Shell Company | false | | |
Entity Public Float | | | $ 28,754,000 |
Entity Common Stock, Shares Outstanding | | 17,708,968 | |
Documents Incorporated by Reference [Text Block] | Portions of the Definitive Proxy Statement for the registrant’s 2023 Annual Meeting of Stockholders to be held May 17, 2023, are incorporated by reference into Part III, Items 10-14 of this Annual Report on Form 10-K. | | |
ICFR Auditor Attestation Flag | false | | |
Auditor Name | WHITLEY PENN LLP | | |
Auditor Location | Plano, Texas | | |
Auditor Firm ID | 726 | | |